Stockreport

Rani Therapeutics (RANI) Is Up 257.9% After $1.08 Billion Chugai Deal and $60M Fundraise—What's Changed [Yahoo! Finance]

Rani Therapeutics Holdings, Inc. - Class A  (RANI) 
PDF joint development and commercialization of an oral product combining Rani's RaniPill oral delivery technology and Chugai's rare disease antibody, potentially valued at o [Read more]